Sweden
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 20.68
|
Dec. 31, 2023 | USD 26.00 | 1.16% |
|
Sweden |
|
2 |
USD 12.91
|
Dec. 31, 2023 | USD 17.18 | 2.59% |
|
Sweden |
|
3 |
USD 11.53
|
Dec. 31, 2023 | USD 16.63 | 0.49% |
|
Sweden |
|
4 |
USD 10.58
|
Dec. 31, 2023 | USD 52.21 | -0.68% |
|
Sweden |
|
5 |
USD 8.79
|
Dec. 31, 2023 | USD 14.61 | 2.17% |
|
Sweden |
|
6 |
USD 8.51
|
Dec. 31, 2023 | USD 1.35 | -1.92% |
|
Sweden |
|
7 |
USD 7.84
|
Dec. 31, 2023 | USD 12.08 | 1.50% |
|
Sweden |
|
8 |
USD 6.77
|
Dec. 31, 2023 | USD 28.64 | 0.87% |
|
Sweden |
|
9 |
USD 5.80
|
Dec. 31, 2023 | USD 19.07 | 4.08% |
|
Sweden |
|
10 |
USD 5.44
|
Dec. 31, 2023 | USD 31.10 | 0.68% |
|
Sweden |
|
11 |
USD 5.31
|
Dec. 31, 2023 | USD 28.08 | 0.23% |
|
Sweden |
|
12 |
USD 4.29
|
April 30, 2024 | USD 5.39 | -0.39% |
|
Sweden |
|
13 |
USD 3.98
|
Dec. 31, 2023 | USD 3.30 | 3.88% |
|
Sweden |
|
14 |
USD 3.50
|
Dec. 31, 2023 | USD 4.73 | 3.81% |
|
Sweden |
|
15 |
USD 3.05
|
Dec. 31, 2023 | USD 51.72 | -0.10% |
|
Sweden |
|
16 |
USD 2.94
|
Dec. 31, 2023 | USD 20.58 | 0.68% |
|
Sweden |
|
17 |
USD 2.80
|
Dec. 31, 2023 | USD 18.76 | 3.89% |
|
Sweden |
|
18 |
USD 2.56
|
Dec. 31, 2023 | USD 18.25 | 2.79% |
|
Sweden |
|
19 |
USD 2.49
|
Dec. 31, 2023 | USD 11.98 | -2.51% |
|
Sweden |
|
20 |
USD 1.97
|
Dec. 31, 2023 | USD 42.37 | 0.78% |
|
Sweden |
|
21 |
USD 1.83
|
Dec. 31, 2023 | USD 1.76 | 2.86% |
|
Sweden |
|
22 |
USD 1.56
|
Dec. 31, 2023 | USD 3.31 | 2.33% |
|
Sweden |
|
23 |
USD 1.45
|
Dec. 31, 2023 | USD 3.87 | 2.52% |
|
Sweden |
|
24 |
USD 1.45
|
Dec. 31, 2023 | USD 0.89 | 14.73% |
|
Sweden |
|
25 |
USD 1.39
|
April 30, 2024 | USD 22.17 | -0.20% |
|
Sweden |
|
26 |
USD 1.27
|
Dec. 31, 2023 | USD 9.75 | -0.95% |
|
Sweden |
|
27 |
USD 1.24
|
Dec. 31, 2023 | USD 2.57 | -0.02% |
|
Sweden |
|
28 |
USD 1.22
|
Dec. 31, 2023 | USD 0.97 | -2.02% |
|
Sweden |
|
29 |
USD 1.15
|
Dec. 31, 2023 | USD 3.33 | 0.41% |
|
Sweden |
|
30 |
USD 1.06
|
Dec. 31, 2023 | USD 2.19 | 0.18% |
|
Sweden |
|
31 |
USD 1.03
|
Dec. 31, 2023 | USD 10.16 | -0.20% |
|
Sweden |
|
32 |
USD 0.90
|
Dec. 31, 2023 | USD 32.97 | -0.61% |
|
Sweden |
|
33 |
USD 0.74
|
Dec. 31, 2023 | USD 3.41 | 3.24% |
|
Sweden |
|
34 |
USD 0.73
|
Dec. 31, 2023 | USD 0.28 | 0.36% |
|
Sweden |
|
35 |
USD 0.73
|
Dec. 31, 2023 | USD 2.97 | 0.98% |
|
Sweden |
|
36 |
USD 0.69
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
37 |
USD 0.57
|
Dec. 31, 2023 | USD 3.19 | 2.10% |
|
Sweden |
|
38 |
USD 0.51
|
April 30, 2024 | USD 1.60 | -0.43% |
|
Sweden |
|
39 |
USD 0.36
|
Dec. 31, 2023 | USD 0.78 | 5.47% |
|
Sweden |
|
40 |
USD 0.32
|
April 30, 2024 | USD 0.47 | -0.26% |
|
Sweden |
|
41 |
USD 0.30
|
Dec. 31, 2023 | USD 0.09 | 1.68% |
|
Sweden |
|
42 |
USD 0.25
|
Dec. 31, 2023 | USD 2.91 | -2.20% |
|
Sweden |
|
43 |
USD 0.25
|
Dec. 31, 2023 | USD 0.28 | 6.05% |
|
Sweden |
|
44 |
USD 0.24
|
Dec. 31, 2023 | USD 0.28 | -7.61% |
|
Sweden |
|
45 |
USD 0.24
|
Dec. 31, 2023 | USD 2.09 | -2.04% |
|
Sweden |
|
46 |
USD 0.20
|
Dec. 31, 2023 | USD 0.61 | 0.68% |
|
Sweden |
|
47 |
USD 0.20
|
Dec. 31, 2023 | USD 1.88 | 0.68% |
|
Sweden |
|
48 |
USD 0.19
|
Dec. 31, 2023 | USD 0.15 | 3.82% |
|
Sweden |
|
49 |
USD 0.17
|
Aug. 31, 2024 | USD 0.30 | -1.39% |
|
Sweden |
|
50 |
USD 0.15
|
Dec. 31, 2023 | USD 1.42 | 3.80% |
|
Sweden |
The Pharmaceuticals company in Sweden with the highest Revenue Per Share is Essity AB (publ) (Stockholm Stock Exchange: ESSITY-B.ST) at USD 20.68.
The Pharmaceuticals company in Sweden with the lowest Revenue Per Share is Modus Therapeutics Holding AB (publ) (Stockholm Stock Exchange: MODTX.ST) at USD 0.00.
The top 10 Pharmaceuticals companies in Sweden by Revenue Per Share are Essity AB (publ), Medicover AB (publ), Getinge AB (publ), MedCap AB (publ), Teqnion AB (publ), New Nordic Healthbrands AB (publ), AddLife AB (publ), Swedish Orphan Biovitrum AB (publ), Stille AB and Probi AB (publ).
The bottom 10 Pharmaceuticals companies in Sweden by Revenue Per Share are Modus Therapeutics Holding AB (publ), SynAct Pharma AB, Moberg Pharma AB (publ), Scandinavian Real Heart AB (Publ), AlzeCure Pharma AB (publ), Xspray Pharma AB (publ), Guard Therapeutics International AB (publ), Ascelia Pharma AB (publ), Vicore Pharma Holding AB (publ) and Cantargia AB (publ).